SEC-sourced researchBeta
VVOS
Vivos Therapeutics, Inc.
Company comparison ↗
Data passport
- CIK
- 0001716166
- Exchange
- Nasdaq
- Business activity
- — · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Oct 1, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 15,031,000.0000 | Apr 15, 2026 |
| December 2025 | 17,443,000.0000 | Apr 15, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 17,443,000.0000 | -21,170,000.0000 | -15,263,000.0000 | 25,152,000.0000 | 26,702,000.0000 | Apr 15, 2026 |
| December 2024 | 15,031,000.0000 | -11,136,000.0000 | -12,691,000.0000 | 15,284,000.0000 | 7,330,000.0000 | Apr 15, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $17.44M | December 2025 | Apr 15, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $15.03M | December 2024 | Apr 15, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$21.17M | December 2025 | Apr 15, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$15.26M | December 2025 | Apr 15, 2026 | 10-K |
| Total assetsAssets | $25.15M | December 2025 | Apr 15, 2026 | 10-K |
| Total liabilitiesLiabilities | $26.7M | December 2025 | Apr 15, 2026 | 10-K |
New filings
- 8-KVVOS · Vivos Therapeutics, Inc.Oct 1, 2026 · Current event
- 4VVOS · Vivos Therapeutics, Inc.Sep 18, 2026 · Other
- 4VVOS · Vivos Therapeutics, Inc.Sep 18, 2026 · Other
- 4VVOS · Vivos Therapeutics, Inc.Sep 18, 2026 · Other
- 8-K/AVVOS · Vivos Therapeutics, Inc.Sep 8, 2026 · Current event
- 8-KVVOS · Vivos Therapeutics, Inc.Sep 8, 2026 · Current event
- SCHEDULE 13G/AVVOS · Vivos Therapeutics, Inc.Sep 3, 2026 · Other
- 10-KVVOS · VIVOS THERAPEUTICS, INC.Apr 15, 2026 · Annual